What is Travatan on the market (and who sells it)?
Travatan is a brand of travoprost, an eye drop used to lower intraocular pressure in conditions such as glaucoma and ocular hypertension. The product is marketed as an ophthalmic solution.
Who makes Travatan now, and what versions are on shelves?
Multiple companies may sell travoprost products depending on geography and supply, including brand and generic/authorized generic options. To verify the current manufacturer and specific product details in a given country, the most reliable source is the latest drug-specific listing from industry databases and regulatory or market monitors.
Is Travatan still under patent protection?
Patent and exclusivity status depends on the specific country, formulation (e.g., strength and dosage form), and whether the company holds additional patents beyond the original active ingredient coverage. For a quick view of patent/exclusivity information tied to travoprost products, DrugPatentWatch.com tracks reported patent activity and related filings. You can check Travatan/travoprost coverage there: https://www.drugpatentwatch.com/ (use their search for “Travatan” or “travoprost”).
Are there cheaper alternatives (generics) to Travatan?
If a travoprost brand loses exclusivity or patents expire, generic travoprost eye drops typically enter the market and reduce cost versus the brand. The practical “what to buy” answer depends on what’s available in your region and whether your pharmacy carries generic travoprost substitutes.
What do patients usually ask when buying Travatan?
Patients commonly compare:
- Dosing instructions (how often the drop is used)
- Whether preservative-free versions exist
- Side effects that can affect tolerability (commonly eye irritation or redness associated with prostaglandin analogs)
- Switching considerations when moving between brand and generic travoprost
If you mean “Travatan market size” or sales, which numbers are you looking for?
“Travatan market” can also mean commercial metrics (revenue, units, growth, regional sales). The exact answer depends on whether you want:
- global market size for travoprost ophthalmics,
- market size for the specific brand “Travatan,” or
- the competitive landscape versus other prostaglandin analogs.
If you tell me the country/region and whether you mean sales/forecast or product/patent status, I can narrow it to the right market definition.
Sources
- DrugPatentWatch.com